AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 41 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 410 | -30.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 591 | -29.8% | 0.00% | – |
| Q1 2022 | $2,000 | -60.0% | 842 | -29.2% | 0.00% | – |
| Q4 2021 | $5,000 | – | 1,190 | +118900.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q1 2021 | $7,000 | -87.0% | 1,315 | -87.0% | 0.00% | – |
| Q4 2020 | $54,000 | +500.0% | 10,138 | +418.6% | 0.00% | – |
| Q3 2020 | $9,000 | -50.0% | 1,955 | -46.0% | 0.00% | – |
| Q2 2020 | $18,000 | +125.0% | 3,620 | +1.3% | 0.00% | – |
| Q1 2020 | $8,000 | +100.0% | 3,574 | +486.9% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 609 | -7.4% | 0.00% | – |
| Q3 2019 | $2,000 | -50.0% | 658 | -35.3% | 0.00% | – |
| Q2 2019 | $4,000 | -84.0% | 1,017 | -72.2% | 0.00% | – |
| Q1 2019 | $25,000 | +316.7% | 3,662 | +317.6% | 0.00% | – |
| Q4 2018 | $6,000 | -76.9% | 877 | -39.9% | 0.00% | – |
| Q3 2018 | $26,000 | – | 1,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $11,479,000 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 695,258 | $813,000 | 2.80% |
| Latash Investments, LLC | 243,134 | $284,000 | 0.23% |
| Bracebridge Capital, LLC | 428,571 | $501,000 | 0.09% |
| Running Point Capital Advisors, LLC | 10,000 | $12,000 | 0.01% |
| D.B. Root & Company, LLC | 12,500 | $14,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 406,700 | $475,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 142,956 | $167,000 | 0.00% |
| IFP Advisors, Inc | 6,500 | $104,000 | 0.00% |
| Financial Advocates Investment Management | 27,000 | $32,000 | 0.00% |